Literature DB >> 1317887

Myofibroblasts in hepatitis B related cirrhosis and hepatocellular carcinoma.

K Y Chau1, M A Lily, P C Wu, W L Yau.   

Abstract

Peritoneal liver biopsy specimens from eight patients with hepatitis B associated cirrhosis, complicated by hepatocellular carcinoma, were studied for identification and localisation of myofibroblasts. The avidin-biotin peroxidase complex technique was used on paraffin wax sections, using monoclonal antibodies for actin and desmin, and ultrastructural examination was performed. Myofibroblasts were found in seven of the eight cirrhotic specimens and in all eight tumour specimens. They were identified in the fibrotic areas by the immunohistochemical technique, but ultrastructural examination disclosed their presence in the perisinusoidal space and between tumour cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317887      PMCID: PMC495313          DOI: 10.1136/jcp.45.5.446

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

Review 1.  The myofibroblast in breast disease.

Authors:  A Ahmed
Journal:  Pathol Annu       Date:  1990

Review 2.  Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis.

Authors:  A M Gressner; M G Bachem
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

3.  Tumour desmoplasia inhibits angiogenesis.

Authors:  S H Barsky; L L Nelson; V A Levy
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

4.  Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice.

Authors:  S H Barsky; R Gopalakrishna
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

5.  HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues.

Authors:  T Tsukada; M A McNutt; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens.

Authors:  W F Grigioni; S Garbisa; A D'Errico; P Baccarini; W G Stetler-Stevenson; L A Liotta; A M Mancini
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

7.  Hepatocellular carcinoma. Polygonal cell type with fibrous stroma--an atypical variant with a favorable prognosis.

Authors:  M M Berman; N P Libbey; J H Foster
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

8.  Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

Authors:  C L Arteaga; A K Tandon; D D Von Hoff; C K Osborne
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

9.  Contractile fibroblasts in chronic alcoholic cirrhosis.

Authors:  R Rudolph; W J McClure; M Woodward
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

10.  Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications.

Authors:  H C Hsu; T T Wu; M Z Wu; J C Sheu; C S Lee; D S Chen
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

  10 in total
  1 in total

1.  Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells.

Authors:  Zhi-Ming Wang; Le-Yuan Zhou; Bin-Bin Liu; Qin-An Jia; Yin-Ying Dong; Yun-Hong Xia; Sheng-Long Ye
Journal:  Mol Med Rep       Date:  2014-07-31       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.